Alterations in the PI3K/AKT/mTOR pathway are now thought to be strongly associated with the carcinogenesis and progression of endometrial cancer (Slomovitz and Coleman, 2012; Chen et al., 2014). The gene discussed is AKT1; the disease is endometrial cancer.